Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B

Angus, Peter; W. McCaughan, Geoffrey; Gane, Edward; H.G. Crawford, Darryl; Harley, Hugh

doi:10.1053/jlts.2000.8310

Public

Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B

Published in Liver Transplantation • Jul 1, 2000

Authors:

Peter Angus

Geoffrey W. McCaughan

Edward Gane

Abstract

Although antiviral prophylaxis with lamivudine monotherapy appears to reduce post-liver transplantation recurrence of hepatitis B virus (HBV) infection, breakthrough infections occur in at least 20% of the patients because of the development of drug resistance. Combined lamivudine and intravenous he...

Subject

Lamivudine

Medicine

HBsAg

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!